Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian

Breadcrumb

  1. Home
  2. What are the links between respiratory syncytial virus and gut microbiota?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. What are the links between respiratory syncytial virus and gut microbiota?

What are the links between respiratory syncytial virus and gut microbiota?

Respiratory infection
Pulmonology Gastroenterology

When respiratory syncytial virus infects the lungs, the severity of the disease is correlated to specific bacterial profiles in the gut microbiota. This provides further evidence of the existence of an intestine-lung axis.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 27 October 2020
Updated 06 October 2021

Most people contract a respiratory syncytial virus (RSV) infection before the age of one. While symptoms are limited to a mild upper respiratory tract infection in most infants, 0.5%–2% of them develop a severe infection of the lower respiratory tract, such as bronchiolitis or pneumonia, requiring hospitalization. There is currently no vaccine or other preventive treatment for RSV.

Phylogenetic clusters

With the links between the intestinal microbiota and respiratory health becoming increasingly clear, a research team compared the microbiota of 37 healthy infants to that of 58 hospitalized infants with confirmed moderate or severe RSV infection. A fecal analysis using 16S RNA sequencing showed no significant differences in microbial diversity (alpha) among the three groups. However, the analysis did reveal phylogenetic clusters able to discriminate not only RSV infants from the control subjects, but also the 53 moderate cases from the 5 severe cases. In particular, when compared to the control subjects, infants with severe RSV infection showed an increased abundance of the S24-7 bacterial family in their gut microbiota, whereas bacteria from Moraxellaceae, Tissierella and Soehngenia families were found to be reduced

S24-7: a severity marker?

Within the S24-7 family, (sidenote: Operational Taxonomic Unit groups of organisms usually not cultivated or not identified, classified on the basis of the similarity of the DNA sequencing of a given gene. Frequently used as an equivalent to the concept of species )  191 was of particular interest to the researchers, since it was more abundant in the severe cases than in either the control subjects or moderate cases. OUT 191 may therefore be an indicator of the severity of the disease. The hypothetic mechanism of action could be a potential interaction with the immune system. S24-7 bacteria carry genes that code for enzymes that degrade IgA, an immunoglobulin involved in the protection of mucous membranes and the prevention of upper respiratory tract infections. However, available data do not reveal whether S24-7 bacteria are the cause or the result of RSV infection, especially since IgA degradation or a modification of immune responses may be caused by other metabolites in the microbiota that are not associated with S24-7 bacteria. In any case, this study lays the groundwork for identifying microbial clusters associated with RSV infection and its severity. It may help identify infants at risk of developing severe RSV infection and lead to the development of immunoprotective microbial mixes.

 

Sources

Harding JN, Siefker D, Vu L, et al. Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity. BMC Microbiol. 2020;20(1):140.

Tags
Respiratory Virus Microbiome Flora
    Created 27 October 2020
    Updated 06 October 2021

    About this article

    To know more about this topic.

    Main topic

    Respiratory infection

    Medical practice

    Pulmonology Gastroenterology

    Content type

    News

    Continue reading

    News
    14.03.2025

    Nasal mycobiota responsible for rhinitis and asthma?

    Read the article
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    17.06.2025

    The HACK index: identifying keystone gut species for better patient outcomes

    Read the article
    11.06.2025

    How menopause impacts microbiota

    Read the article
    04.06.2025

    A handful of bacteria are the signature of chronic pain

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo